Lantheus Holdings (LNTH)

Nasdaq Health Care Health Care Supplies S&P MidCap 400

$100.61

-0.09 (-0.09%)

Close of Nov 06, 2026 · end-of-day data

Source: Lantheus Holdings's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$301.85M	$331.38M	$343.37M	$347.34M	$339.41M	$425.21M	$935.06M	$1.30B	$1.53B	$1.54B
Cost of revenue	$164.07M	$169.24M	$168.49M	$172.53M	$200.65M	$237.51M	$353.36M	$586.89M	$545.62M	$599.66M
Gross profit	$137.78M	$162.13M	$174.88M	$174.81M	$138.76M	$187.69M	$581.70M	$709.54M	$988.29M	$941.95M
Research & development	$12.20M	$18.12M	$17.07M	$20.02M	$32.79M	$44.97M	$311.68M	$77.71M	$168.10M	$177.31M
Operating income	$56.59M	$51.85M	$64.49M	$51.66M	-$4.20M	-$60.83M	$36.20M	$364.64M	$456.98M	$310.83M
Interest expense	$26.62M	$18.41M	$17.41M	$13.62M	$9.48M	$7.75M	$7.18M	$20.02M	$19.67M	$19.75M
Pre-tax income	$28.29M	$39.64M	$49.55M	$28.63M	-$11.48M	-$75.04M	$26.72M	$410.94M	$430.98M	$313.79M
Income tax	$1.53M	-$83.75M	$9.03M	-$3.04M	$1.99M	-$3.76M	-$1.35M	$84.28M	$118.53M	$80.23M
Net income	$26.76M	$123.39M	$40.52M	$31.67M	-$13.47M	-$71.28M	$28.07M	$326.66M	$312.44M	$233.56M
EBITDA	$73.92M	$70.04M	$77.26M	$63.75M	$19.05M	-$18.54M	$84.12M	$424.69M	$521.60M	$380.93M
EPS (basic)	$0.84	$3.31	$1.06	$0.81	$-0.25	$-1.06	$0.41	$4.79	$4.52	$3.46
EPS (diluted)	$0.82	$3.17	$1.03	$0.79	$-0.25	$-1.06	$0.40	$4.65	$4.36	$3.41
Diluted shares	32.66M	38.89M	39.50M	40.11M	54.13M	67.49M	70.67M	70.24M	71.65M	68.44M
Gross margin	45.6%	48.9%	50.9%	50.3%	40.9%	44.1%	62.2%	54.7%	64.4%	61.1%
Operating margin	18.7%	15.6%	18.8%	14.9%	-1.2%	-14.3%	3.9%	28.1%	29.8%	20.2%
Net margin	8.9%	37.2%	11.8%	9.1%	-4.0%	-16.8%	3.0%	25.2%	20.4%	15.2%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$51.18M	$76.29M	$113.40M	$92.92M	$79.61M	$98.51M	$415.65M	$713.66M	$912.81M	$359.12M
Receivables	$36.82M	$40.26M	$43.75M	$43.53M	$54.00M	$89.34M	$213.40M	$284.29M	$321.26M	$358.64M
Inventory	$17.64M	$26.08M	$33.02M	$29.18M	$35.74M	$35.13M	$35.48M	$64.03M	$68.03M	$64.67M
Total current assets	$110.82M	$147.85M	$195.41M	$172.91M	$184.22M	$235.79M	$677.62M	$1.09B	$1.33B	$899.96M
Goodwill	$15.71M	$15.71M	$15.71M	$15.71M	$58.63M	$61.19M	$61.19M	$61.19M	$61.19M	$239.52M
Total assets	$255.90M	$383.86M	$439.83M	$405.92M	$869.82M	$863.78M	$1.32B	$1.65B	$1.98B	$2.23B
Total current liabilities	$43.84M	$46.75M	$52.76M	$66.11M	$80.50M	$90.50M	$247.70M	$187.35M	$240.53M	$333.42M
Short-term debt	$3.65M	$2.75M	$2.75M	$10.14M	$20.70M	$11.64M	$354.00K	$823.00K	$974.00K	$738.00K
Long-term debt	$274.46M	$265.39M	$263.71M	$183.93M	$197.70M	$163.12M	$557.71M	$561.67M	$565.28M	$568.68M
Total debt	$278.11M	$268.14M	$266.46M	$194.07M	$218.40M	$174.76M	$558.07M	$562.49M	$566.25M	$569.42M
Total liabilities	$362.41M	$360.57M	$368.83M	$291.32M	$355.62M	$399.35M	$874.11M	$835.26M	$892.33M	$1.14B
Shareholders' equity	-$106.52M	$23.29M	$71.00M	$114.60M	$514.21M	$464.44M	$447.15M	$815.89M	$1.09B	$1.09B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$49.64M	$54.78M	$61.19M	$80.38M	$16.40M	$53.92M	$281.78M	$305.26M	$544.75M	$390.14M
Capital expenditures	$7.40M	$17.54M	$20.13M	$22.06M	$0	$0	$260.00M	$45.34M	$51.62M	$36.09M
Free cash flow	$42.24M	$37.23M	$41.06M	$58.32M	$16.40M	$53.92M	$21.78M	$259.92M	$493.12M	$354.05M
Investing cash flow	$3.28M	-$16.31M	-$19.13M	-$22.06M	-$4.91M	$3.68M	-$276.55M	$5.94M	-$226.01M	-$627.17M
Financing cash flow	-$30.22M	-$13.45M	-$4.67M	-$78.88M	-$21.86M	-$39.33M	$311.69M	-$13.06M	-$118.54M	-$316.58M
Share buybacks	—	—	—	—	$0	$0	$75.00M	$0	$100.00M	$300.02M
Stock-based compensation	$2.52M	$5.93M	$8.72M	$12.49M	$14.07M	$15.93M	$29.26M	$50.51M	$76.39M	$85.56M
Depreciation & amortization	$17.33M	$18.19M	$12.77M	$12.09M	$23.25M	$42.29M	$47.93M	$60.04M	$64.62M	$70.10M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$354.00M	$369.98M	$394.09M	$378.73M	$391.11M	$372.76M	$378.05M	$384.01M	$406.79M	$377.33M	$388.18M	$389.91M
Cost of revenue	$124.13M	$128.13M	$138.32M	$136.61M	$142.56M	$135.06M	$137.03M	$161.65M	$165.91M	$146.41M	$146.32M	$146.50M
Gross profit	$229.87M	$241.85M	$255.77M	$242.13M	$248.54M	$237.70M	$241.01M	$222.37M	$240.88M	$230.92M	$241.85M	$243.41M
Research & development	$16.82M	$48.02M	$60.60M	$24.15M	$35.33M	$36.31M	$45.49M	$48.02M	$47.48M	$39.38M	$38.20M	$92.76M
Operating income	$137.49M	$106.64M	$102.73M	$133.74M	$113.87M	$102.07M	$87.97M	$43.62M	$77.18M	$81.33M	$100.22M	$32.21M
Interest expense	$5.04M	$4.86M	$4.86M	$4.90M	$5.04M	$4.80M	$4.92M	$4.95M	$5.08M	$4.86M	$4.92M	$4.94M
Pre-tax income	$138.40M	$171.27M	$84.37M	$176.12M	-$783.00K	$96.53M	$104.52M	$42.38M	$70.36M	$156.41M	$93.83M	$21.78M
Income tax	$35.02M	$40.20M	$22.30M	$45.02M	$11.01M	$23.58M	$25.76M	$14.61M	$16.28M	$37.99M	$18.80M	-$594.00K
Net income	$103.38M	$131.07M	$62.07M	$131.09M	-$11.79M	$72.94M	$78.75M	$27.77M	$54.09M	$118.42M	$75.03M	$22.37M
EBITDA	$152.50M	$122.08M	$117.55M	$150.82M	$131.16M	$115.69M	$101.20M	$64.02M	$100.02M	$104.01M	$122.80M	$55.10M
EPS (basic)	$1.52	$1.91	$0.89	$1.89	$-0.17	$1.06	$1.15	$0.41	$0.83	$1.83	$1.15	$0.34
EPS (diluted)	$1.47	$1.87	$0.88	$1.79	$-0.19	$1.02	$1.12	$0.41	$0.81	$1.80	$1.11	$0.33
Diluted shares	-29.00K	70.09M	70.60M	73.06M	320.00K	71.46M	70.31M	67.66M	-595.00K	65.77M	67.52M	68.41M
Gross margin	64.9%	65.4%	64.9%	63.9%	63.5%	63.8%	63.8%	57.9%	59.2%	61.2%	62.3%	62.4%
Operating margin	38.8%	28.8%	26.1%	35.3%	29.1%	27.4%	23.3%	11.4%	19.0%	21.6%	25.8%	8.3%
Net margin	29.2%	35.4%	15.8%	34.6%	-3.0%	19.6%	20.8%	7.2%	13.3%	31.4%	19.3%	5.7%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$713.66M	$718.28M	$757.02M	$866.39M	$912.81M	$938.53M	$695.57M	$382.01M	$359.12M	$498.58M	$593.30M	$683.61M
Receivables	$284.29M	$337.39M	$372.29M	$329.34M	$321.26M	$348.75M	$336.58M	$351.38M	$358.64M	$355.67M	$352.89M	$345.68M
Inventory	$64.03M	$69.76M	$70.52M	$70.83M	$68.03M	$69.13M	$62.16M	$62.04M	$64.67M	$61.34M	$57.55M	$64.21M
Total current assets	$1.09B	$1.15B	$1.23B	$1.30B	$1.33B	$1.42B	$1.20B	$925.09M	$899.96M	$942.29M	$1.03B	$1.12B
Goodwill	$61.19M	$61.19M	$61.19M	$61.19M	$61.19M	$61.19M	$176.87M	$240.33M	$239.52M	$239.40M	$239.05M	$238.63M
Total assets	$1.65B	$1.83B	$1.94B	$2.05B	$1.98B	$2.06B	$2.12B	$2.28B	$2.23B	$2.35B	$2.41B	$2.46B
Total current liabilities	$187.35M	$237.20M	$263.29M	$784.08M	$240.53M	$248.00M	$280.13M	$346.84M	$333.42M	$333.17M	$335.68M	$345.97M
Short-term debt	$823.00K	$734.00K	$868.00K	$564.71M	$974.00K	$747.00K	$796.00K	$871.00K	$738.00K	$803.00K	$697.00K	$605.00K
Long-term debt	$561.67M	$562.47M	$563.19M	$613.00K	$565.28M	$566.10M	$566.85M	$567.94M	$568.68M	$569.60M	$570.35M	$571.14M
Total debt	$562.49M	$563.20M	$564.06M	$565.33M	$566.25M	$566.85M	$567.64M	$568.81M	$569.42M	$570.41M	$571.05M	$571.74M
Total liabilities	$835.26M	$885.79M	$913.15M	$869.92M	$892.33M	$891.03M	$949.29M	$1.16B	$1.14B	$1.13B	$1.10B	$1.10B
Shareholders' equity	$815.89M	$945.54M	$1.03B	$1.18B	$1.09B	$1.16B	$1.17B	$1.12B	$1.09B	$1.21B	$1.31B	$1.36B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$112.29M	$127.24M	$84.72M	$175.06M	$157.73M	$107.56M	$87.11M	$105.29M	$90.18M	$125.13M	$92.20M	$101.97M
Capital expenditures	$0	$8.27M	$11.18M	$15.81M	$16.37M	$8.72M	$7.96M	$10.62M	$8.79M	$3.23M	$2.33M	$2.05M
Free cash flow	$112.29M	$118.97M	$73.55M	$159.25M	$141.36M	$98.84M	$79.14M	$94.67M	$81.39M	$121.90M	$89.87M	$99.93M
Investing cash flow	-$12.07M	-$106.53M	-$45.09M	-$67.80M	-$6.60M	-$63.72M	-$232.47M	-$319.47M	-$11.51M	$25.99M	-$2.02M	-$11.13M
Financing cash flow	-$450.00K	-$16.84M	$99.00K	$1.87M	-$103.66M	-$18.22M	-$98.41M	-$99.17M	-$100.79M	-$11.62M	$4.50M	-$460.00K
Share buybacks	—	—	—	$0	$100.00M	—	—	$100.00M	$100.02M	—	—	$0
Stock-based compensation	$14.17M	$15.38M	$18.48M	$20.37M	$22.16M	$21.20M	$22.32M	$24.50M	$17.54M	$16.04M	$20.01M	$21.88M
Depreciation & amortization	$15.02M	$15.45M	$14.82M	$17.07M	$17.29M	$13.63M	$13.23M	$20.41M	$22.83M	$22.68M	$22.58M	$22.90M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.